A 24-parameter spectral flow cytometry panel was developed to monitor immune receptor expression in MS patients, aiding personalized treatment approaches. The panel detects 12 treatment-associated ...
News-Medical.Net on MSN
Empowering genomics research with cloud-based innovation
In this interview, NewsMedical speaks with Nripesh Prasad, Vice President of Scientific and Technical Development in Genomics ...
Slingshot Biosciences ("Slingshot") today announced two additions to its TruCytes™ cell mimic product line designed to ...
A state-of-the-art research facility providing opportunities for new and bold discoveries through multidisciplinary health ...
Flow cytometry, in particular, is projected to lead the market in 2025, accounting for 38.4% of the total instrument and ...
Holdin announced the Company will exhibit two posters at the European Society of Gene and Cell Therapy 2025 Annual Congress, which ...
Low-dose nivolumab (Opdivo) plus lenalidomide (Revlimid) yielded a promising response with a favorable safety profile in patients with classical Hodgkin lymphoma (cHL), according to a single-arm phase ...
Six Chelmsford High School seniors were honored as Lions Pride/Rotary Students of the Month for September, Principal Stephen ...
Tiger Group and EquipNet will host a timed, online auction on Oct. 16 featuring 400 lots of advanced, lightly used ...
Daily Democrat on MSN
Newly recognized pathway could protect diabetics from hypoglycemia
A new study by UC Davis, shows how cells work together to avoid a sudden drop in blood sugar. Understanding these feedback loops could improve the lives of people with diabetes and help them avoid ...
BIAF--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today announced sales of its CyPath® Lung ...
In the Lancet Child & Adolescent Health Commission on the future of neonatology, Daniele De Luca and colleagues call for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results